Amica Retiree Medical Trust’s Textron TXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$159K Hold
1,880
0.22% 85
2025
Q2
$151K Hold
1,880
0.22% 83
2025
Q1
$136K Sell
1,880
-334
-15% -$25K 0.21% 87
2024
Q4
$169K Hold
2,214
0.16% 91
2024
Q3
$196K Buy
+2,214
New +$195K 0.16% 89
2019
Q3
Sell
-1,056
Closed -$56K 393
2019
Q2
$56K Buy
+1,056
New +$53.6K 0.05% 318
2017
Q2
Sell
-1,962
Closed -$93K 371
2017
Q1
$93K Hold
1,962
0.08% 268
2016
Q4
$95K Sell
1,962
-2,133
-52% -$93K 0.08% 286
2016
Q3
$163K Hold
4,095
0.14% 193
2016
Q2
$150K Hold
4,095
0.13% 199
2016
Q1
$149K Hold
4,095
0.13% 193
2015
Q4
$172K Hold
4,095
0.15% 174
2015
Q3
$154K Hold
4,095
0.14% 182
2015
Q2
$183K Hold
4,095
0.15% 176
2015
Q1
$182K Hold
4,095
0.15% 179
2014
Q4
$172K Hold
4,095
0.14% 192
2014
Q3
$147K Hold
4,095
0.12% 197
2014
Q2
$157K Hold
4,095
0.13% 192
2014
Q1
$161K Hold
4,095
0.14% 182
2013
Q4
$151K Buy
+4,095
New +$126K 0.13% 185

Other funds holding TXT

Amica Retiree Medical Trust's TXT Position: Q3 2025 in Review

Amica Retiree Medical Trust held its Textron (TXT) position steady in Q3 2025 at 1,880 shares worth $159K. The position accounts for 0.22% of the portfolio, ranked #85.

Amica Retiree Medical Trust first reported a position in TXT in Q4 2013 and has held it in 20 quarters since. The position peaked at $196K in Q3 2024. 683 funds tracked by Wall St. Rank hold TXT as of Q3 2025.

  • Amica Retiree Medical Trust held 1,880 shares of Textron worth $159K as of Q3 2025.
  • Amica Retiree Medical Trust left its Textron share count unchanged in Q3 2025.
  • Textron made up 0.22% of Amica Retiree Medical Trust's portfolio in Q3 2025, its #85 holding.
  • Amica Retiree Medical Trust first reported a position in Textron in Q4 2013 and has held it in 20 quarters since.
  • Amica Retiree Medical Trust's Textron position peaked at $196K in Q3 2024.
  • 683 funds tracked by Wall St. Rank held Textron as of Q3 2025.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2025, filed 7 Nov 2025.